Physician profile
Katherine Lee
NPI 1265720551
$1,538.04
in general payments reported to CMS, 2019-2025
28 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $245 · 2021: $142 · 2022: $379 · 2023: $230 · 2024: $70.52 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $499.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $246.15 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $116.81 | 2019-2025 | |
| Pfizer INC. | $105.40 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $73.52 | 2022 | |
| Abbott Laboratories | $72.37 | 2023 | Cardiomems |
| Organon LLC | $67.17 | 2022 | |
| Therapeuticsmd, INC. | $64.51 | 2019-2021 | |
| Evofem Biosciences, INC. | $61.61 | 2021-2022 | |
| Exeltis, USA INC. | $60.74 | 2019-2022 | |
| Shield Therapeutics INC | $58.59 | 2022 | |
| Ethicon US, LLC | $52.47 | 2019-2020 | |
| Channel Medsystems, INC. | $52.22 | 2022-2023 | |
| Meditrina | $49.54 | 2022-2025 | |
| Smith+Nephew, INC. | $49.07 | 2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Hologic Sales and Service, LLC | $46.57 | 2022-2025 | Aptima |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $45.15 | 2025 | Myfembree |
| Myovant Sciences INC. | $35.84 | 2021 | |
| Merck Sharp & Dohme LLC | $33.88 | 2019-2020 | |
| Coopersurgical, INC. | $33.82 | 2019-2023 | Summit Doppler |
| Lupin INC. | $30.09 | 2020 | |
| Allergan, INC. | $28.96 | 2019 | |
| Biogen, INC. | $25.76 | 2024 | |
| Astellas Pharma US INC | $24.89 | 2023 | Veozah |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.85 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.77 | 2019 | |
| Aspira Women'S Health INC | $22.22 | 2024 | Ova1 |
| Olympus America INC. | $18.00 | 2022 | |
| Agile Therapeutics, INC. | $17.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.